CD4 and COVID-19: In the younger group, CD4 SIPhigh level predicted serological responses induced by COVID-19 vaccination ((3/12 25.0%) vs 25/42 (59.5%), p=0.035) compared to patients with CD4 SIPlow (Figures S3D, 4).